World's Best Scientists 2026 revealed!
European Journal of Cancer
H-index 75

European Journal of Cancer

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 91 1341 1850 72

Additional Metrics

Number of Best Scientists*: 2038
Documents by Best Scientists*: 2285
Top 100 Ranked Scientists*: 43
SCIMAGO H-index: 256
SCIMAGO SJR: 2.691
Impact Factor: 7.1

Overview

Top Research Topics at European Journal of Cancer?

European Journal of Cancer mainly deals with areas of study such as Internal medicine, Oncology, Cancer research, Cancer and Breast cancer. The research on Internal medicine featured in it combines topics in other fields like Gastroenterology and Surgery. While Oncology is the focus of European Journal of Cancer, it also provided insights into the studies of Clinical trial, Phases of clinical research, Radiation therapy and Prostate cancer.

The journal explores issues in Cancer research which can be linked to other research areas like Immunology and Pathology. It explores research in Breast cancer and the adjacent study of Gynecology.

  • Internal medicine (42.63%)
  • Oncology (32.14%)
  • Cancer research (16.62%)

What are the most cited papers published in the journal?

  • New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) (15277 citations)
  • Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012 (3806 citations)
  • A survey of telomerase activity in human cancer (2397 citations)

Research areas of the most cited articles at European Journal of Cancer:

The most cited papers are organized to reinforce research efforts on Internal medicine, Cancer, Surgery, Oncology and Breast cancer. Gastroenterology and Endocrinology are some topics wherein Internal medicine research discussed in the journal publications has an impact. The journal publications with studies in Cancer featured incorporate elements of Cancer research and Epidemiology, Incidence (epidemiology), Pathology.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Cancer
  • Disease

The previous edition focused in particular on these issues:

European Journal of Cancer primarily tackles Internal medicine, Oncology, Cancer, Cancer research and Adverse effect. The research on Internal medicine discussed in it draws on the closely related field of Gastroenterology. The journal focuses on Oncology but the discussions also offer insight into other areas such as Immunotherapy, Breast cancer, Melanoma and Confidence interval.

The Cancer works featured in European Journal of Cancer incorporate elements from Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Disease and Vaccination. The research on Cancer research tackled can also make contributions to studies in the areas of Text mining and Cutaneous T-cell lymphoma. The study on Chemotherapy presented in it intersects with the topics under Radiation therapy.

The most cited articles from the last journal are:

  • High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients. (19 citations)
  • SARS-CoV-2 vaccines for cancer patients: a call to action. (15 citations)
  • Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index (15 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in European Journal of Cancer (based on the number of publications) are:

  • Jaap Verweij (122 papers) absent at the last edition,
  • C.J.H. van de Velde (95 papers) absent at the last edition,
  • Dirk Schadendorf (90 papers) published 18 papers at the last edition, 10 more than at the previous edition,
  • Sabine Siesling (76 papers) absent at the last edition,
  • Martine Piccart (76 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in European Journal of Cancer (based on the number of publications) are:

  • Institut Gustave Roussy (698 papers) published 56 papers at the last edition, 10 more than at the previous edition,
  • Netherlands Cancer Institute (512 papers) published 20 papers at the last edition, 6 less than at the previous edition,
  • Erasmus University Rotterdam (507 papers) published 23 papers at the last edition, 4 less than at the previous edition,
  • The Royal Marsden NHS Foundation Trust (470 papers) published 17 papers at the last edition, 1 less than at the previous edition,
  • European Organisation for Research and Treatment of Cancer (429 papers) published 12 papers at the last edition, 5 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 13.93% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 25.97% were posted by at least one author from the top 10 institutions publishing in the journal. Another 17.88% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 16.86% of all publications and 39.29% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Related Studies and Journal Impact

It's important to highlight that the European Journal of Cancer not only provides insightful studies on oncology and internal medicine but its impact goes beyond these realms. Many of the research features, especially in oncology and internal medicine, can greatly contribute to other allied fields of science such as nursing, pharmacology, and even applicable in the course of medical curriculum.

For instance, the clinical trials and research methods discussed could enlighten nursing students and practitioners towards effective patient care and treatment, specifically in the oncology department. Detailed studies from this journal may influence curriculum development on subjects related to oncology, in different nursing programs.

For nursing students or professionals seeking for advanced training and educational programs, we recommend checking out some of the best np programs in Louisiana. Here, course modules are designed with thorough consideration of recent and relevant studies from esteemed journals such as the European Journal of Cancer.

The journal's wide array of topics and featured research greatly affects not just the academic community but also the professional field and the global healthcare industry. Its contributions to cancer research and relevant topics only emphasize its significant role and impact in the academic community and beyond.

Top Publications

  • The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers.

    Tadeusz Dyba;Giorgia Randi;Freddie Bray;Carmen Martos

    (2021)
    433 Citations
  • Global, regional and national burden of primary liver cancer by subtype.

    (2021)
    362 Citations
  • The management of desmoid tumours : A joint global consensus-based guideline approach for adult and paediatric patients

    Ben Alman;Steven Attia;Christina Baumgarten;Charlotte Benson

    (2020)
    354 Citations
  • European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022.

    (2022)
    328 Citations
  • Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies

    Kamal S. Saini;Marco Tagliamento;Matteo Lambertini;Richard McNally

    (2020)
    309 Citations
  • European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022.

    (2022)
    285 Citations
  • European interdisciplinary guideline on invasive squamous cell carcinoma of the skin : Part 2. Treatment

    Alexander J Stratigos;Claus Garbe;Clio Dessinioti;Celeste Lebbe

    (2020)
    264 Citations
  • Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis.

    (2022)
    246 Citations
  • The cost of cancer in Europe 2018.

    Thomas Hofmarcher;Peter Lindgren;Peter Lindgren;Nils Wilking;Bengt Jönsson

    (2020)
    238 Citations
  • European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.

    Alexander J Stratigos;Claus Garbe;Clio Dessinioti;Celeste Lebbe

    (2020)
    205 Citations

Related Online Degrees & Career Pathways

Exploring career options related to studying Medicine in the USA can open doors to diverse healthcare roles. For advanced nursing professionals, the 1 year dnp program online offers an accelerated pathway to obtain a Doctor of Nursing Practice degree quickly, blending flexibility with advanced clinical training.

For those interested in entering the medical field rapidly, fast medical assistant programs provide efficient, streamlined courses that prepare students for essential support roles in healthcare settings within weeks.

Finding the right graduate program is key, and the dnp school options highlight programs that balance accessibility with strong clinical and leadership training, suited for busy professionals aiming to advance their nursing careers.

Additionally, for those focusing on the administrative side of healthcare, medical coding courses offer affordable and convenient training to become certified medical coders, an essential role in managing patient data and insurance claims.

Best Scientists Contributing to This Journal

Recently Published Articles